A. Originalarbeiten peer reviewed vor W2-Ernennung (1998-2009)
Frodl T, Meisenzahl EM, Gallinat J, Hegerl U, Möller HJ (1998). Markers from event-related potential subcomponents and reaction time for information processing dysfunction in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 248:307-13. (Impact: 1.048 ) (IF von 1999, da 1998 nicht bekannt)
Meisenzahl EM, Gottschalk S, Lechner C, Lehmann R (1998). Die spontane perimesencephale Subarachnoidalblutung (PMH). Eine eigene Krankheitsentität mit guter Prognose? Fortschr Neurol Psychiatr. 66(9):387-90. (Impact: 0.602) (IF von 1999, da 1998 nicht bekannt)
Wegner U, Meisenzahl EM, Möller HJ, Kapfhammer HP (1999). Dysmorphophobie: Symptom oder Diagnose ? Nervenarzt. 70 (3):233-9. (Impact: 0.684)
Lechner C, Meisenzahl EM, Uhlemann H, Helber-Böhlen H, Fähndrich H (1999). Hallervorden-Spatz-Erkrankung: eine seltene Differentialdiagnose der präsenilen Demenz. Nervenarzt. 70(5):471-5. (Impact: 0.684)
Meisenzahl EM, Frodl T, Greiner J, Leinsinger G, Maag K, Heiss D, Hahn K, Hegerl U, Möller HJ (1999). Corpus callosum size in schizophrenia - a magnetic resonance imaging analysis. Eur Arch Psychiatry Clin Neurosci. 249(6):305-12. (Impact: 1.048)
Dresel S, Mager T, Rossmüller B, Meisenzahl EM, Hahn K, Möller HJ, Tatsch K (1999). In vivo effects of olanzapine on striatal dopamine D2/D3 receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study. Eur J Nucl Med. 26(8):862-8. (Impact: 3.239)
Frodl-Bauch T, Gallinat J, Meisenzahl EM, Möller HJ, Hegerl U (1999). P300 subcomponents reflect different aspects of psychopathology in schizophrenia. Biol Psychiatry. 45:116-26. (Impact: 3.319)
Tigges P, Mergl R, Frodl T, Meisenzahl EM, Gallinat J, Schröter A, Riedel M, Müller N, Möller HJ, Hegerl U (2000). Digitized analysis of abnormal hand motor performance in schizophrenic patients. Schizophr Res. 45(1-2):133-43. (Impact: 3.506)
Meisenzahl EM, Frodl T, Zetzsche T, Leinsinger G, Heiss D, Maag K, Hegerl U, Hahn K, Möller HJ (2000). Adhesio interthalamica in male patients with schizophrenia. Am J Psychiatry. 157(5):823-5. (Impact: 6.577)
Meisenzahl EM, Dresel S, Tatsch K, Frodl T, Schmitt GJE, Preuss UW, Ross-Müller B, Mager T, Hahn K, Möller HJ (2000). D2 receptor occupancy under re-commended and high doses of olanzapine: an iodine-123-Iodobenzamide SPECT Study. J Psychopharmacol. 14(4):364-70. (Impact: 2.328)
Frodl T, Meisenzahl EM, Müller D, Greiner J, Juckel G, Leinsinger G, Hahn H, Möller HJ, Hegerl U (2001). Corpus Callosum and P300 in schizophrenia. Schizophr Res. 49(1-2):107-19. (Impact: 3.567)
Zetzsche T, Meisenzahl EM, Preuss UW, Holder JJ, Leinsinger G, Hahn K, Möller HJ (2001). In vivo analysis of the human planum temporale (PT): Does the definition of PT borders influence the results with regard to asymmetry and correlation with handedness? Psychiatry Res-Neuroimaging. 107(2):99-115. (Impact: 2.354)
Meisenzahl EM, Rujescu D, Kirner A, Giegling I, Kathmann N, Leinsinger G, Maag K, Hegerl U, Hahn K, Möller HJ (2001). Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia. Am J Psychiatry. 158(8):1316-9. (Impact 6.913)
Frodl T, Meisenzahl EM, Müller D, Leinsinger G, Juckel G, Hahn K, Möller HJ, Hegerl U (2001). The effect of the skull on event-related P300. Clin Neurophysiol. 112(9):1773-6. (Impact: 1.922)
Frodl T, Meisenzahl EM, Müller D, Holder J, Juckel G, Möller HJ, Hegerl U (2002). P300 subcomponents and clinical symptoms in schizophrenia. Int J Psychophysiol. 43:237-46. (Impact: 2.055)
Rujescu D, Meisenzahl EM, Kirner A, Giegling I, Leinsinger G, Hegerl U, Hahn K, Möller HJ (2002). Methionine homozygosity at codon 129 in the prion protein is associated with enlargement of CSF compartments in healthy volunteers and schizophrenic patients. Neuroimage. 15(1):200-6. (Impact: 5.624)
Frodl T, Meisenzahl EM, Zetzsche T, Bottlender R, Born C, Groll C, Jäger M, Leinsinger G, Hahn K, Möller HJ (2002). Enlargement of the amygdala volume in patients with a first episode of major depression. Biol Psychiatry. 51(9):708-14. (Impact: 5.915)
Frodl T, Meisenzahl EM, Zetzsche T, Born C, Groll C, Jäger M, Leinsinger G, Bottlender R, Hahn K, Möller HJ (2002). Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry. 159 (7):1112-8. (Impact: 6.458)
Meisenzahl EM, Zetzsche T, Preuss U, Frodl T, Leinsinger G, Möller HJ (2002). Planum temporale in schizophrenia: Does the definition of borders influence the results? Am J Psychiatry. 159(7):1198-1200. (Impact: 6.458)
Schmitt GJE, Meisenzahl EM, Dresel S, Tatsch K, Rossmüller B, Frodl T, Preuss UW, Hahn K, Möller HJ (2002). Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by iodine-123-Iodobenzamide SPECT: a comparative study with olanzapine. J Psychopharmacol. 16(3):200-6. (Impact: 3.173)
Meisenzahl EM, Frodl T, Zetzsche T, Leinsinger G, Maag K, Hegerl U, Hahn K, Möller HJ (2002). An investigation of possible diencephalic pathology in schizophrenia. Psychiatry Res. Neuroimaging. 115:127-35. (Impact: 2.231)
Preuss UW, Meisenzahl EM, Frodl T, Zetzsche T, Holder J, Leinsinger G, Hegerl U, Hahn K, Möller HJ (2002). Handedness and corpus callosum morphology. Psychiatry Res Neuroimaging. 116:33-42. (Impact: 2.231)
Frodl T, Meisenzahl EM, Müller D, Holder J, Juckel G, Möller HJ, Hegerl U (2002). P300 subcomponents and clinical symptoms in schizophrenia. Int J Psychophysiol. 43(3): 237-46. (Impact: 2.055)
Frodl T, Meisenzahl EM, Zetzsche T, Born C, Jäger M, Groll C, Bottlender R, Leinsinger G, Möller HJ (2003). Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects. Biol Psychiatry. 53(4):338-44. (Impact: 6.039)
Frodl T, Meisenzahl EM, Zill P, Baghai T, Rujescu D, Leinsinger G, Bottlender R, Schule C, Zwanzger P, Engel RR, Rupprecht R, Bondy B, Reiser M, Möller HJ (2004). Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch Gen Psychiatry. 61(2):177-83. (Impact: 11.207)
Meisenzahl EM, Frodl T, Müller D, Schmitt GJE, Gallinat J, Zetzsche T, Marcuse A, Juckel G, Leinsinger G, Hahn K, Möller HJ, Hegerl U (2004). Superior temporal gyrus and P300 in schizophrenia: a combined ERP/structural magnetic resonance imaging investigation. J Psychiatr Res. 38:153-62. (Impact: 3.078)
Born CM, Meisenzahl EM, Frodl T, Pfluger T, Reiser M, Möller HJ, Leinsinger GL (2004). The septum pellucidum and its variants. An MRI study. Eur Arch Psychiatry Clin Neurosci. 254(5):295-302. (Impact: 1.870)
Frodl T, Meisenzahl EM, Zetzsche T, Hohne T, Banac S, Schorr C, Jager M, Leinsinger G, Bottlender R, Reiser M, Möller HJ (2004). Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J Clin Psychiatry. 65(4):492-9. (Impact: 4.806)
La Fougère C, Meisenzahl EM, Schmitt G, Stauss J, Frodl T, Tatsch K, Hahn K, Möller HJ, Dresel S (2005). D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study. J Nucl Med. 46(6):1028-33. (Impact: 4.684)
Preuss UW, Zetzsche T, Jäger M, Groll C, Frodl T, Bottlender R, Leinsinger G, Hegerl U, Hahn K, Möller HJ, Meisenzahl EM (2005). Thalamic volumes in first-episode and chronic schizophrenic subjects. Schizophr Res. 73:91-101. (Impact: 4.231)
Schmitt GJ, Meisenzahl EM, Frodl T, La Fougère C, Hahn K, Möller HJ, Dresel S (2005). The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1. J Psychopharmacol. 19(5):488-93. (Impact: 3.178)
Schmitt GJ, Frodl T, Dresel S, la Fougère C, Bottlender R, Koutsouleris N, Hahn K, Möller HJ, Meisenzahl EM (2006). Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients. Eur Arch Psychiatry Clin Neurosci. 256(2):115-21. (Impact: 3.042)
Zetzsche T, Frodl T, Preuss UW, Schmitt G, Seifert D, Leinsinger G, Born C, Reiser M, Möller HJ, Meisenzahl EM (2006). Amygdala volume and depressive symptoms in patients with borderline personality disorder. Biol Psychiatry. 60(3):302-10. (Impact: 7.154)
Frodl T, Schaub A, Banac S, Zetzsche T, Charypar M, Jäger M, Kümmler P, Groll C, Bottlender R, Leinsinger G, Möller HJ, Meisenzahl EM (2006). Reduced hippocampal volume correlates with executive dysfunction in major depression. J Psychiatry Neurosci. 31(5):316-23. (Impact: 4.100)
Gallinat J, Meisenzahl EM, Jacobsen LK, Kalus P, Bierbrauer J, Kienast T, Witthaus H, Leopold K, Seifert F, Schubert F, Staetgen M (2006). Smoking and structural brain deficits: a volumetric MR investigation. Eur J Neurosci, 24(6):1744-50. (Impact: 3.709)
Meisenzahl EM, Scheuerecker J, Zipse M, Ufer S, Wiesmann M, Frodl T, Koutsouleris N, Zetzsche T, Schmitt G, Riedel M, Spellmann I, Dehning S, Linn J, Möller HJ (2006). Effects of treatment with the atypical neuroleptic quetiapine on working memory function: A functional MRI follow-up investigation. Eur Arch Psychiatry Clin Neurosci. 256(8):522-31. (Impact: 3.042)
Schneider F, Habel U, Reske M, Kellermann T, Stocker T, Shah NJ, Zilles K, Braus DF, Schmitt A, Schlosser R, Wagner M, Frommann I, Kircher T, Rapp A, Meisenzahl EM, Ufer S, Ruhrmann S, Thienel R, Sauer H, Henn FA, Gaebel W (2007). Neural correlates of working memory dysfunction in first-episode schizophrenia patients. Schizophr Res. 89(1-3):198-210. (Impact: 4.240)
Zetzsche T, Preuss UW, Frodl T, Schmitt G, Seifert D, Münchhausen E, Tabrizi S, Leinsinger G, Born C, Reiser M, Möller HJ, Meisenzahl EM (2007). Hippocampal volume reduction and history of aggressive behaviour in patients with borderline personality disorder. Psychiatry Res: Neuroimaging. 154(2):157-70. (Impact: 2.275)
Rujescu D*, Meisenzahl EM, Krejcova S, Giegling I, Zetzsche T, Reiser M, Born CM, Möller HJ, Veske A, Gal A, Finckh U (2007). Plexin B3 is genetically associated with verbal performance and white matter volume in brain. Mol Psychiatry. 12(2):190-4. (Impact: 10.900) (* equally contributed)
Frodl T, Schüle C, Schmitt G, Born C, Bahai T, Zill P, Bottlender R, Rupprecht R, Bondy B, Reiser M, Möller HJ, Meisenzahl EM (2007). Association of brain-derived neurotrophic factor Val66met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry. 64:410-16. (Impact: 15.976)
Frodl T, Scheuerecker J, Albrecht J, Kleemann AM, Müller-Schunk S, Koutsouleris N, Möller HJ, Brückmann H, Wiesmann M, Meisenzahl EM (2007). Neuronal correlates of emotional processing in patients with major depression. World J Biol Psychiatry. 26:1-7. (Impact: 1.691)
Zetzsche T, Preuss U, Frodl T, Watz D, Schmitt G, Koutsouleris N, Born C, Reiser M, Möller HJ, Meisenzahl EM (2007). In-vivo topography of structural alterations of the anterior cingulate in patients with schizophrenia: new findings and comparison with the literature. Schizophr Res. 96(1-3):34-45. (Impact 4.240)
Scheuerecker J, Frodl T, Koutsouleris N, Zetzsche T, Wiesmann M, Kleemann AM, Brückmann M, Schmitt G, Möller HJ, Meisenzahl EM (2007). Cerebral differences in explicit and implicit emotional processing - an fMRI study. Neuropsychobiology. 56(1):32-9. (Impact: 1.992)
Zetzsche T, Preuss UW, Frodl T, Leinsinger G, Hegerl U, Möller HJ, Meisenzahl EM (2007). White matter alterations in schizophrenic patients with pronounced negative symptomatology and with positive family history for schizophrenia. Eur Arch Psychiatry Clin Neurosci. (5):278-84. (Impact: 2.809)
Frodl T, Zetzsche T, Jäger M, Born C, Ritter S, Kraft E, Bottlender R, Leinsinger G, Reiser M, Möller HJ, Meisenzahl EM (2008). Volumetric increase in the emotional division of the anterior cingulate cortex in major depression. Psychiatry Res Neuroimaging. 163:76-83. (Impact: 2.638)
Frodl T, Jäger M, Born C, Ritter S, Kraft E, Zetzsche T, Bottlender R, Leinsinger G, Reiser M, Möller HJ, Meisenzahl EM (2008). Anterior cingulate cortex does not differ between patients with major depression and healthy controls, but relatively large anterior cingulate cortex predicts a good clinical course. Psychiatry Res. 163(1):76-83. (Impact: 2.666)
Koutsouleris N, Gaser C, Bottlender R, Jäger M, Frodl T, Schmitt G , Reiser M, Born C, Möller HJ, Meisenzahl EM (2008). Structural correlates of psychopathological symptom dimensions in schizophrenia: a VBM study. Neuroimage. 39(4):1600-12. (Impact: 5.694)
Schmitt GJ, la Fougère C, Dresel S, Frodl T, Hahn K, Möller HJ, Meisenzahl EM (2008). Dual-isotope SPECT imaging of striatal dopamine: First episode drug naive schizophrenic patients. Schizophr Res. 101(1-3):133-41. (Impact 4.174)
Scheuerecker J, Ufer S, Zipse M, Frodl T, Koutsouleris N, Zetzsche T, Wiesmann M, Albrecht J, Brückmann H, Schmitt G, Möller HJ, Meisenzahl EM (2008). Cerebral changes and cognitive dysfunctions in medication-free schizophrenia - An fMRI study. J Psychiatr Res. 42(6):469-76. (Impact 4.679)
Frodl T, Zill P, Baghai T, Rujescu D, Leinsinger G, Bottlender R, Schüle C, Zwanzger P, Engel RR, Rupprecht R, Bondy B, Reiser M, Möller HJ, Meisenzahl EM (2008). Reduced hippocampal volumes associated with the long variant of the tri- and diallelic serotonin transporter polymorphism in major depression. Am J Med Genet B Neuropsychiatr Genet. 147 (7):1003-7. (Impact: 3.932)
Zetzsche T, Preuss UW, Bondy B, Frodl T, Zill P, Schmitt G, Koutsouleris N, Rujescu D, Born C, Reiser M, Möller HJ, Meisenzahl EM (2008). 5-HT1A receptor gene C-1019 G polymorphism and amygdala volume in borderline personality disorder. Genes Brain Behav. 7(3):306-13. (Impact: 3.890)
Juckel G, Gudlowski Y, Müller D, Özgürdal S, Brüne M, Gallinat J, Frodl T, Witthaus H, Uhl I, Wutzler A, Pogarell O, Mulert C, Hegerl U, Meisenzahl EM (2008). Loudness dependence of the auditory evoked N1/P2-component as an indicator of serotonergic dysfunction in patients with schizophrenia – a replication study. Psychiatry Res. 158(1):79-82. (Impact: 2.666)
Frodl T, Jäger M, Smajstrlova I, Born C, Bottlender R, Palladino T, Reiser M, Möller HJ, Meisenzahl EM (2008). Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci. 33(5):423-30. (Impact: 4.123)
Meisenzahl EM, Schmitt G, Gründer G, Dresel S, Frodl T, la Fougère C, Scheuerecker J, Schwarz M, Boerner R, Stauss J, Hahn K, Möller HJ (2008). Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study. Pharmacopsychiatry. 41(5):169-75. (Impact: 2.402)
Meisenzahl EM, Koutsouleris N, Bottlender R, Scheuerecker J, Jäger M, Teipel SJ, Holzinger S, Frodl T, Preuss U, Schmitt G, Burgermeister B, Reiser M, Born C, Möller HJ. (2008). Structural brain alterations at different stages of schizophrenia: A voxel-based morphometric study. Schizophr Res. 104(1-3):44-60. (Impact: 4.174)
Meisenzahl EM, Koutsouleris N, Gaser C, Bottlender R, Schmitt GJ, McGuire P, Decker P, Burgermeister B, Born C, Reiser M, Möller HJ. (2008). Structural brain alterations in subjects at high-risk of psychosis: a voxel-based morphometric study. Schizophr Res. 102(1-3):150-62. (Impact: 4.174)
Preuss UW, Rujescu D, Giegling I, Watzke S, Koller G, Zetzsche T, Meisenzahl EM, Soyka M, Möller HJ (2008). [Psychometric evaluation of the German version of the Barratt Impulsiveness Scale] Nervenarzt. 79(3):305-19. (Impact: 0.814)
Frodl T, Koutsouleris N, Bottlender R, Jäger M, Born C, Scupin I, Reiser M, Möller HJ, Meisenzahl EM (2008). Depression-related long-term Decline of Brain Morphology: Stress-toxicity? Archives of General Psychiatry. 65(10):1156-65. (Impact: 14.273)
Frodl T, Koutsouleris N, Bottlender R, Jäger M, Born C, Mörgenthaler M, Rupprecht R, Bondy B., Reiser M, Möller HJ, Meisenzahl EM (2008). Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Mol Psychiatry. 13(12):1093-101.(Impact: 12.537)
Scheuerecker J, Ufer S, Käpernick M, Wiesmann M, Brückmann H, Kraft E, Möller HJ, Meisenzahl EM (2008). Cerebral network deficits in post-acute catatonic schizophrenia measured by fMRI. Schizophr Res. 43 (6):607-14. (Impact: 4.174)
Koutsouleris N, Meisenzahl EM, Davatzikos C, Bottlender R, Frodl T, Scheuerecker J, Schmitt G, Burgermeister B, Reiser M, Möller HJ, Gaser C (2008). Neuroanatomical pattern classification identifies subjects in at risk mental state of psychosis and predicts disease transition. Arch Gen Psychiatry. 66 (7): 700-12. (Impact: 14.273) (* equally contributed)
Zetzsche T, Preuss UW, Frodl T, Leinsinger G, Born C, Reiser M, Hegerl U, Möller HJ, Meisenzahl EM (2008). White matter alterations in schizophrenic patients with pronounced negative symptomology and white positive family history for schizophrenia. Eur Arch Psychiatry Clin Neurosci. 258(5):278-84. (Impact: 2.852)
Scheuerecker J, Ufer S, Käpernick M, Wiesmann M, Brückmann H, Kraft E, Seifert D, Koutsouleris N, Möller HJ, Meisenzahl EM (2009). Cerebral network deficits in post-acute catatonic schizophrenic patients measured by fMRI. J Psychiatr Res. 43(6):607-14. (Impact: 3.723)
Koutsouleris N, Bottlender R, Decker P, Gaser C Scheuerecker J, Schmitt G Burgermeister B, Born C, Reiser M, Möller HJ, Meisenzahl EM (2009). Structural Brain Correlates of the Early and Late At-Risk Mental States of Psychosis in Relation to Clinical Outcome. Br J Psychiatry. 195 (3):218-26. (Impact: 5.777)
Schmitt GJ, Meisenzahl EM, Frodl T, La Fougère C, Hahn K, Möller HJ, Dresel S (2009). Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [123I] IBZM SPECT. Psychiatry Res Neuroimaging. 173(3):183-9. (Impact: 3.435)
Feddersen B, de la Fontaine L, Sass JO, Lutz J, Abicht A, Klopstock T, Verma IC, Meisenzahl EM, Pogarell O (2009). Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE) Mimicking Anorexia Nervosa. Am J Psychiatry. 166(4):494-5. (Impact: 12.522)
Koutsouleris N, Schmitt GJ, Gaser C, Bottlender R, Scheuerecker J, McGuire P, Burgermeister B, Born C, Reiser M, Möller HJ, Meisenzahl EM (2009). Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomes. Br J Psychiatry. 195(3):218-26. (Impact: 5.777)
Koutsouleris N, Meisenzahl EM, Davatzikos C, Bottlender R, Frodl T, Scheuerecker J, Schmitt G, Zetzsche T, Decker P, Reiser M, Möller HJ, Gaser C (2009). Use of neuroantomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry. 66(7):700-12. (Impact: 12.257)
Frodl T, Scheuerecker J, Albrecht J, Kleemann AM, Müller-Schunk S, Koutsouleris N, Möller HJ, Brückmann H, Wiesmann M, Meisenzahl EM (2009). Neuronal correlates of emotional processing in patients with major depression. World J Biol Psychiatry. 10(3):202-8. (Impact: 5.564)
